✦ LIBER ✦

Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis

✍ Scribed by Mengu Sarioglu; Cigdem Tuzun; Zeliha Unlu; Canan Tikiz; Fatma Taneli; B. Sami. Uyanik

Publisher: Springer
Year: 2004
Tongue: English
Weight: 231 KB
Volume: 26
Category: Article
ISSN: 0172-8172
DOI: 10.1007/s00296-004-0544-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of alendronate and risedronate o

Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis

✍ Aysegul Atmaca; Olcay Gedik 📂 Article 📅 2006 🏛 Springer Healthcare Communications 🌐 English ⚖ 279 KB

Effect of alendronate on bone mineral de

Effect of alendronate on bone mineral density and bone turnover in Thai postmenopausal osteoporosis

✍ La-or Chailurkit; Wallaya Jongjaroenprasert; Sasithorn Rungbunnapun; Boonsong On 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 189 KB

Comparison of the effect of alendronate

Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis

✍ Jun Iwamoto; Tsuyoshi Takeda; Yoshihiro Sato; Mitsuyoshi Uzawa 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 121 KB

Effects of denosumab on bone turnover ma

Effects of denosumab on bone turnover markers in postmenopausal osteoporosis

✍ Richard Eastell; Claus Christiansen; Andreas Grauer; Stepan Kutilek; Cesar Liban 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 272 KB 👁 1 views

## Abstract Denosumab, a fully human monoclonal antibody to RANKL, decreases bone remodeling, increases bone density, and reduces fracture risk. This study evaluates the time course and determinants of bone turnover marker (BTM) response during denosumab treatment, the percentage of denosumab‐treat

Effect of alendronate on bone mineral de

Effect of alendronate on bone mineral density and bone turnover markers in post-gastrectomy osteoporotic patients

✍ Jun Iwamoto; Mitsuyoshi Uzawa; Yoshihiro Sato; Tsuyoshi Takeda; Hideo Matsumoto 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 168 KB

Effects of bazedoxifene on bone mineral

Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal japanese women with osteoporosis

✍ Akira Itabashi; Kousei Yoh; Arkadi A Chines; Takami Miki; Masahiko Takada; Hiros 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 244 KB 👁 2 views

## Abstract This randomized, double‐blind, placebo‐controlled, dose‐response late phase 2 study evaluated the efficacy and safety of bazedoxifene in postmenopausal Japanese women 85 years of age or younger with osteoporosis. Eligible subjects received daily treatment with oral doses of bazedoxifene